+Search query
-Structure paper
Title | Structure-based design of non-hypertrophic apelin receptor modulator. |
---|---|
Journal, issue, pages | Cell, Vol. 187, Issue 6, Page 1460-1475.e20, Year 2024 |
Publish date | Mar 14, 2024 |
Authors | Wei-Wei Wang / Su-Yu Ji / Wenjia Zhang / Junxia Zhang / Chenxi Cai / Rubi Hu / Shao-Kun Zang / Luwei Miao / Haomang Xu / Li-Nan Chen / Zongkuai Yang / Jia Guo / Jiao Qin / Dan-Dan Shen / Ping Liang / Yan Zhang / Yan Zhang / |
PubMed Abstract | Apelin is a key hormone in cardiovascular homeostasis that activates the apelin receptor (APLNR), which is regarded as a promising therapeutic target for cardiovascular disease. However, adverse ...Apelin is a key hormone in cardiovascular homeostasis that activates the apelin receptor (APLNR), which is regarded as a promising therapeutic target for cardiovascular disease. However, adverse effects through the β-arrestin pathway limit its pharmacological use. Here, we report cryoelectron microscopy (cryo-EM) structures of APLNR-G complexes bound to three agonists with divergent signaling profiles. Combined with functional assays, we have identified "twin hotspots" in APLNR as key determinants for signaling bias, guiding the rational design of two exclusive G-protein-biased agonists WN353 and WN561. Cryo-EM structures of WN353- and WN561-stimulated APLNR-G protein complexes further confirm that the designed ligands adopt the desired poses. Pathophysiological experiments have provided evidence that WN561 demonstrates superior therapeutic effects against cardiac hypertrophy and reduced adverse effects compared with the established APLNR agonists. In summary, our designed APLNR modulator may facilitate the development of next-generation cardiovascular medications. |
External links | Cell / PubMed:38428423 |
Methods | EM (single particle) |
Resolution | 2.4 - 3.2 Å |
Structure data | EMDB-38794, PDB-8xzf: EMDB-38795, PDB-8xzg: EMDB-38796, PDB-8xzh: EMDB-38797, PDB-8xzi: EMDB-38798, PDB-8xzj: EMDB-38967: The focused refinement map (Receptor) of the MM07 bound APLNR-Gi1 structure. EMDB-38969: The focused refinement map (G-protein) of MM07 bound APLNR-Gi1 structure. EMDB-38970: The low resolution consensus map of the MM07 bound APLNR-Gi1 structure. EMDB-38971: The focused refinement map (Receptor) of CMF-019 bound APLNR-Gi1 structure. EMDB-38972: The focused refinement map (G-protein) of CMF-019 bound APLNR-Gi1 structure. EMDB-38973: CMF-019 bound APLNR complex EMDB-38974: The focused refinement map (Receptor) of WN353 bound APLNR-Gi1 structure EMDB-38975: The focused refinement map (G-protein) of WN353 bound APLNR-Gi1 structure EMDB-38976: WN353 bound APLNR complex EMDB-38977: The focused refinement map (Receptor) of WN561 bound APLNR-Gi1 structure. EMDB-38978: The focused refinement map (G-protein) of WN561 bound APLNR-Gi1 structure EMDB-38979: WN561 bound APLNR complex |
Chemicals | PDB-1d5n: |
Source |
|
Keywords | MEMBRANE PROTEIN / APLNR / Class A GPCR / Synthetic peptide / apelin / Structural protein / MM07 / Cyclic peptide / CMF-019 / G-protein-biased small molecule agonist |